医用大麻:摩洛哥制药行业日益增长的机会
Ali Cherif Chefchaouni1, Ismail Bennani2, Soumaya El Baraka3
1Department of Drug Science, Faculty of Medicine, Pharmacy and Dental Medicine of Fez, Sidi Mohamed Ben Abdellah University, Fez, Morocco; Faculty of Medicine, Pharmacy and Dental Medicine of Fez, Sidi Mohamed Ben Abdellah University, Fez, Morocco; Department of Pharmacy, Hospital Omar Drissi, Hassan II University Hospital of Fez, Fez, Morocco.
Annales pharmaceutiques francaises
|December 20, 2025
概括
摩洛哥正在利用其新的大麻法来发展其制药业,探索各种治疗用途和多种剂量形式的医用大麻. 这使得该国成为大麻研究和生产的枢纽.
科学领域:
- 制药科学 制药科学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 摩洛哥颁布了13-21号法律,授权大麻用于医疗,制药和工业用途.
- 这项立法为发展国家制药业开辟了道路.
- 大麻在各种医疗领域具有显著的治疗潜力.
研究的目的:
- 审查医用大麻的制药和性潜力.
- 探索摩洛哥制药产业发展的机会.
- 突出摩洛哥在医用大麻研究和生产方面的战略地位.
主要方法:
- 关于大麻制药和质性质的文献综述.
- 分析摩洛哥的监管框架和制药生态系统.
- 评估大麻素的治疗应用和配方可能性.
主要成果:
- 摩洛哥已经推出了其首个本地生产的基于大麻素的药物.
- 穆罕默德六世理工大学与大麻相关活动监管国家机构之间建立了合作伙伴关系.
- 大麻素在治疗疼痛,神经,精神,瘤和眼科疾病方面表现有前途.
- 大麻可以配制成不同的剂量形式,包括口服溶液,囊,喷雾剂和透皮贴片.
结论:
- 摩洛哥的制药行业由于其制造能力和仿制药市场,有利于整合医用大麻.
- 该国正在将自己确立为医用大麻的研究,生产和制药开发的战略区域枢纽.
相关概念视频
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
651
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
651
Drug Control Governance: Regulatory Bodies and Their Impact
462
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
462
Prescription, Nonprescription and Orphan Drugs
1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
Pharmaceutical Equivalents
171
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
171
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175


